Posted by Michael Wonder on 28 Apr 2025
New treatment against Duchenne muscular dystrophy
25 April 2025 - Duvyzat can be used in a wide patient population from the age of six.
EMA has recommended granting a conditional marketing authorisation in the European Union for Duvyzat (givinostat) as a treatment for Duchenne muscular dystrophy in patients from the age of six who are able to walk.
